While iron is essential for life-sustaining chemical reactions and energy production, its free form is destructive to DNA, proteins, and cell membranes. Ankur Jain and his team discovered that cells maintain high concentrations of polyamines to neutralize this threat. Experiments using a newly developed fluorescent sensor revealed a direct correlation: as polyamine levels decrease, the concentration of reactive, toxic iron rises.

The study, published in the journal Cell, suggests that cancer cells may survive polyamine-depletion therapies by relying on the protein GPX4 to mitigate iron damage. This finding points toward potential combination treatments that block both polyamine production and GPX4 activity to force cancer cell death. Beyond oncology, the research offers a biological link to Parkinson's disease, where mutations affecting polyamine transport coincide with observed iron accumulation in the brain. The new fluorescent sensor technology is expected to provide a vital tool for tracking real-time iron dynamics in future neurodegeneration and aging research.